Effect of Rosuvastatin in contrast induced nephropathy
Phase 2
- Conditions
- Effect of Rosuvostatin in contrast induced nephropathy in chronic kidney disease.chronic kidney diseaseN18.3
- Registration Number
- IRCT20090905002417N21
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 350
Inclusion Criteria
absence of Statin use during past 3 months
eGFR between 30 - 60 cc/min/1.73m2
not pregnant
absence use of contrast during past 10 days
absence use of Metformin
Exclusion Criteria
Acute coronary syndrome
history of allergy to contrast media
death during 72 hours after receiving contrast media
end stage renal disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum creatinin level. Timepoint: 48 hours after contrast media use. Method of measurement: autoanalyser.
- Secondary Outcome Measures
Name Time Method